Jinyu Bio-technology Co., Ltd.

Equities

600201

CNE000000Y37

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
8.91 CNY -2.20% Intraday chart for Jinyu Bio-technology Co., Ltd. +1.14% -17.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Taihe Technologies' Chief Financial Officer Resigns MT
Jinyu Bio-Technology's Unit Ties Up With Shanghai Lanque Biomedicine for African Swine Fever Vaccine Development MT
Jinyu Bio-Technology Teams Up with RNA Cure to Develop mRNA Vaccine for African Swine Fever MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jinyu Bio-Technology's Unit Cattle Vaccine Passes Emergency Evaluation in China MT
Jinyu Bio-Technology Wins Nod to Market Veterinary Vaccine MT
Jinyu Bio-technology Co., Ltd.(XSSC:600201) added to S&P Global BMI Index CI
Jinyu Bio-technology Co., Ltd.(XSSC:600201) added to FTSE All-World Index CI
Jinyu Bio-Technology Registers Veterinary Vaccine For Sheep MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jinyu Bio-Technology Selling 800 Million Yuan Shares to Expand Animal Vaccine Production MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022. CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022. CI
Jinyu Bio-technology Co., Ltd.'s Equity Buyback announced on April 8, 2022, has closed with 33,001,600 shares, representing 2.97% for CNY 289.98 million. CI
Inner Mongolia JinYu Holdings Proposes Agenda Addition for JinYu Biological Technology's 2023 Employee Stock Ownership Plan CI
Jinyu Bio-Technology’s Chairman, Vice Chairman to Become Actual Controllers After 800 Million Yuan Deal MT
Jinyu Bio-technology Co., Ltd. announced that it expects to receive CNY 799.999997 million in funding from Inner Mongolia Jinyu Biological Holdings Co., Ltd., and other investors CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022. CI
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022. CI
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022. CI
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chart Jinyu Bio-technology Co., Ltd.
More charts
JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
8.91 CNY
Average target price
9.58 CNY
Spread / Average Target
+7.52%
Consensus
  1. Stock Market
  2. Equities
  3. 600201 Stock
  4. News Jinyu Bio-technology Co., Ltd.
  5. Jinyu Bio-Technology’s Chairman, Vice Chairman to Become Actual Controllers After 800 Million Yuan Deal